Dr. Jacques Galipeau, Director of the Program for Advanced Cellular Therapy, was invited to speak at the 23rd Congress of the Asia-Pacific Blood and Marrow Transplantation. He presented the symposium, “Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities,” on November 3, 2018.
The 23rd Congress of APBMT was held at the Taipei International Convention Center in Taipei, Taiwan, November 2-4, 2018, and is co-hosted by the Taiwan Society of Blood and Marrow Transplantation and the Society of Taiwan. Many BMT experts take part in the Congress, which is designed to provide a comprehensive overview of the latest research developments in BMT.